Through the Early Adopter Health Network initiative, OBIO partners Canadian companies developing health technologies that are ready for adoption with health organizations (e.g., acute, primary care, long-term care, home and community care).
OBIO supports health technology companies and health organizations in the EAHN:
To evaluate prospective health technologies
To widely disseminate and adopt technologies that demonstrate a proven benefit to patients and result in efficiencies and cost savings to the health system; and
To create showcase sites for the effective adoption of technologies and to demonstrate Canadian technologies to a global market.
OBIO EAHN CALL FOR APPLICATIONS TO ADDRESS COVID-19
OBIO has issued a call for applications for the clinical evaluation of technologies that will aid in the management of COVID-19 or the treatment of COVID-19 patients. Given the urgency necessary to address the COVID-19 pandemic, OBIO is interested in supporting the evaluation of technologies with relatively short clinical evaluation pathways to demonstrate improvement in the treatment response of COVID-19 patients. Companies which meet this criteria are highly encouraged to submit an expression of interest. Companies developing health technologies that are ready for adoption and whose application is outside COVID-19 are also encouraged to apply.
Click here to learn about eligibility/apply.